 |
dinutuximab |
|---|---|
| Trade Name | Unituxin |
| Orphan Indication | Neuroblastoma |
| USA Market Approval | USA |
| USA Designation Date | 2010-12-20 00:00:00 |
| Sponsor | United Therapeutics Corporation;55 TW Alexander Drive;Research Triangle Park, North Carolina, 27709 |
Related Access Program
South Plains Oncology Consortium – Recurrent Neuroblastoma
Catalyst Pharmaceuticals, Inc. – Downbeat Nystagmus
South Plains Oncology Consortium – Neuroblastoma
British Columbia Cancer Agency – Neuroblastoma
South Plains Oncology Consortium – Neuroblastoma
Children’s Hospital of Philadelphia – Neuroblastoma
University of California, San Francisco – Neuroblastoma
Jubilant DraxImage Inc. – Neuroblastoma
Children’s Hospital Medical Center, Cincinnati – Neuroblastoma
Apeiron Biologics AG – Neuroblastoma